Literature DB >> 24979252

Gene therapy for obesity: progress and prospects.

Mingming Gao1, Dexi Liu.   

Abstract

Advances in understanding the molecular basis of obesity and obesity-associated diseases have made gene therapy a vital approach in coping with this world-wide epidemic. Gene therapy for obesity aims to increase or decrease gene product in favor of lipolysis and energy expenditure, leading toward fat reduction and loss of body weight. It involves successful delivery and expression of therapeutic genes in appropriate cells. The ultimate goal of gene therapy is to restore and maintain energy homeostasis. Here we summarize progress made in recent years in identifying genes responsible for obesity and present examples where the gene therapy approach has been applied to treating or preventing obesity. Discussion on advantages and limitations of gene therapy strategies employed is provided. The intent of this review is to inspire further studies toward the development of new strategies for successful treatment of obesity and obesity-associated diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24979252

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  5 in total

Review 1.  Genetic advancements in obesity management and CRISPR-Cas9-based gene editing system.

Authors:  Muthukumaran Jayachandran; Zhaoliang Fei; Shen Qu
Journal:  Mol Cell Biochem       Date:  2022-07-31       Impact factor: 3.842

2.  Cold Exposure Improves the Anti-diabetic Effect of T0901317 in Streptozotocin-Induced Diabetic Mice.

Authors:  Mingming Gao; Chunbo Zhang; Yongjie Ma; Dexi Liu
Journal:  AAPS J       Date:  2015-03-05       Impact factor: 4.009

3.  Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPARγ.

Authors:  Cassandra B Higgins; Yiming Zhang; Allyson L Mayer; Hideji Fujiwara; Alicyn I Stothard; Mark J Graham; Benjamin M Swarts; Brian J DeBosch
Journal:  JCI Insight       Date:  2018-08-23

4.  High-fat diet-induced adiposity, adipose inflammation, hepatic steatosis and hyperinsulinemia in outbred CD-1 mice.

Authors:  Mingming Gao; Yongjie Ma; Dexi Liu
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

Review 5.  Safety and efficacy of naltrexone for weight loss in adult patients - a systematic review.

Authors:  Agnieszka Kulak-Bejda; Grzegorz Bejda; Napoleon Waszkiewicz
Journal:  Arch Med Sci       Date:  2020-09-10       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.